Dancing Towards Stability: The Therapeutic Potential of Argentine Tango for Balance and Mobility in Parkinson’s Disease
Diseases,
Год журнала:
2025,
Номер
13(3), С. 82 - 82
Опубликована: Март 13, 2025
Background:
Parkinson’s
Disease
(PD)
is
a
progressive
neurodegenerative
disorder
characterized
by
motor
impairments,
including
balance
deficits,
gait
disturbances,
and
postural
instability.
Given
the
limitations
of
pharmacological
treatments,
alternative
rehabilitative
strategies
such
as
Argentine
Tango
(AT)
have
been
explored
for
their
potential
benefits
in
improving
mobility
quality
life
individuals
with
PD.
This
systematic
review
evaluates
effectiveness
AT
enhancing
balance,
gait,
functional
PD
patients.
Methods:
A
literature
search
was
conducted
across
PubMed,
Cochrane
Central
Register
Controlled
Trials
(CENTRAL),
Scopus,
PEDro,
Web
Science.
Studies
were
included
if
they
randomized
controlled
trials
(RCTs)
assessing
impact
on
outcomes
Data
extraction
risk
bias
assessment
performed
independently
two
reviewers
using
Risk
Bias
2
(RoB
2)
tool.
Results:
Five
included,
sample
sizes
ranging
from
10
to
62
participants
intervention
durations
varying
weeks
24
months.
significantly
improved
(Mini-BESTest,
BBS,
FRT),
performance
(6MWT,
TUG),
compared
usual
care
or
conventional
exercise.
Some
studies
also
reported
psychological
benefits,
reduced
depressive
symptoms
increased
confidence.
However,
freezing
inconclusive,
methodological
limitations,
small
inconsistent
durations,
noted.
Outcomes
(FoG)
remained
inconclusive
due
variability
methods
reporting
studies.
Conclusions:
appears
be
an
effective
rehabilitation
strategy
While
preliminary
evidence
suggests
additional
larger,
high-quality
are
needed
confirm
its
long-term
efficacy
establish
standardized
protocols.
may
integrated
into
multimodal
programs
enhance
psychosocial
management.
heterogeneity
limit
generalizability
findings.
serve
structured
approach
could
community-based
clinical
programs.
Язык: Английский
Neuroprotective effect of cedrol in a male rat model of Parkinson's disease
Physiological Reports,
Год журнала:
2025,
Номер
13(7)
Опубликована: Апрель 1, 2025
Abstract
Cedrol
is
a
natural
sesquiterpene
subgroup
of
terpenes
with
antioxidant
and
anti‐inflammatory
properties.
This
study
evaluated
the
effect
cedrol
on
6‐hydroxydopamine
(6‐OHDA)
rat
model
Parkinson's
disease
(PD).
Unilateral
injection
6‐OHDA
was
performed
to
induce
PD
model.
at
10
mg/kg
20
administrated.
The
rotarod
test,
apomorphine‐induced
rotational
open
field
tests
assessed
motor
function,
while
passive
avoidance
test
used
evaluate
cognitive
function.
Furthermore,
striatal
levels
malondialdehyde
(MDA)
total
thiol,
SOD
(superoxide
dismutase)
activity
were
measured.
induction
lesion
led
significantly
higher
number
rotations
in
lower
maintenance
as
well
shorter
delay
for
entering
into
longer
duration
time
spent
dark
chamber
versus
control
group.
It
also
enhanced
MDA
diminished
level
thiol.
Administration
improved
behavioral
biochemical
assays.
could
benefit
functions
PD.
Its
properties
might
mediate
these
effects.
Язык: Английский
Parkinson’s Disease Detection Using InceptionV3: A Deep Learning Approach
M S Pallavi,
Madhwesh Bayari,
G Abhilash
и другие.
MethodsX,
Год журнала:
2025,
Номер
unknown, С. 103333 - 103333
Опубликована: Апрель 1, 2025
Parkinson's
disease
(PD)
is
a
neurodegenerative
condition
that
progressively
affects
motor
function
and
causes
tremors,
rigidity,
bradykinesia.
Detection
of
PD
at
an
early
stage
important
to
ensure
timely
intervention
better
patient
outcomes.
This
study
uses
deep
learning
algorithms
classify
spiral
images
traced
by
patients
as
inexpensive
diagnostic
technique
for
the
detection
PD.
A
database
consists
drawn
manually
normal
individuals,
divided
into
training
testing
sets.
To
discriminate
between
drawings
Parkinsonian
healthy
cases
four
Convolutional
Neural
Network
(CNN)
architecture
like
DenseNet121,
InceptionV3,
VGG16,
LeNet
are
used.
Followed
transfer
which
employed
improve
model
performance
extracting
fine
impairment
patterns
in
spirals.
DenseNet121
InceptionV3
achieve
competitive
with
98.44
%
accuracy,
whereas
VGG16
demonstrates
excellent
feature
extraction
performance.
The
emphasizes
relevance
non-invasive
diagnosis,
consistent,
efficient,
automated
method
detection.
future
can
be
directed
towards
combination
other
biomarkers
or
broader
data
set
measures
wider
assessment.•The
focuses
on
enhancing
features
leveraging
hybrid
models,
improving
classification
performance.•Implementation
scaling
leads
performance,
improved
accuracy.•The
comparative
analysis
CNN
provides
valuable
insights
balancing
computational
efficiency
Язык: Английский
Polymer nanocomposite-based biomolecular sensor for healthcare monitoring
Advances in Colloid and Interface Science,
Год журнала:
2025,
Номер
343, С. 103557 - 103557
Опубликована: Май 15, 2025
Язык: Английский
A Stability Indicating RP‐HPLC Method for Determination of Foslevodopa and Foscarbidopa in Bulk and Formulation
Ravisankar Panchumarthy,
Srilakshmi Bathula,
Bhagavan Rajesh Babu Koppisetty
и другие.
Separation Science Plus,
Год журнала:
2025,
Номер
8(5)
Опубликована: Май 1, 2025
ABSTRACT
The
recently
approved
combination
of
foslevodopa
and
foscarbidopa
by
the
United
States
Food
Drug
Administration
provides
a
major
advancement
in
treatment
Parkinson's
disease.
This
therapy
helps
to
maintain
consistent
plasma
levels
levodopa,
thereby
minimizing
overall
symptom
patients.
A
robust
validated
RP‐HPLC
method
has
been
developed
due
novelty
drug
its
recent
approval
regulatory
agencies.
optimized
chromatographic
conditions
included
use
C18
column
(250
×
4.6
mm,
5
µm),
an
isocratic
mobile
phase
acetonitrile:
0.1%
formic
acid
(30:70),
flow
rate
1.0
mL/min,
injection
volume
10
µL,
detection
at
272
nm,
ambient
temperature
25°C,
with
total
runtime
6
min.
Under
these
conditions,
eluted
2.087
min
4.166
System
suitability
parameters,
including
plate
count,
tailing
factor,
%RSD,
were
within
acceptable
limits.
exhibited
high
precision,
%RSD
values
below
2%,
excellent
linearity
over
concentration
range
30–180
µg/mL
for
1.5–9
foscarbidopa.
Sensitivity
analysis
determined
LOD
LOQ
0.480
1.700
0.024
0.084
foscarbidopa,
respectively.
Degradation
studies
confirmed
stability
indicating
capability
under
various
stress
oxidative
causing
highest
degradation.
was
applied
assay
pharmaceutical
formulation
confirming
compliance
label
claims.
Язык: Английский